Detalles de la búsqueda
1.
Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
BMC Cancer
; 20(1): 806, 2020 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32842974
2.
Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
BMC Cancer
; 23(1): 740, 2023 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563548
Resultados
1 -
2
de 2
1
Próxima >
>>